Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Insulet Corp (PODD)

Insulet Corp (PODD)
242.82 +4.25 (+1.78%) 13:37 ET [NASDAQ]
242.45 x 21 243.38 x 7
Realtime by (Cboe BZX)
242.45 x 21 243.38 x 7
Realtime 242.20 +3.63 (+1.52%) 09:30 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
239.37
Day High
246.28
Open 241.83
Previous Close 238.57 238.57
Volume 213,332 213,332
Avg Vol 814,310 814,310
Stochastic %K 26.56% 26.56%
Weighted Alpha +34.90 +34.90
5-Day Change -9.40 (-3.68%) -9.40 (-3.68%)
52-Week Range 160.19 - 289.46 160.19 - 289.46
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,753,815
  • Shares Outstanding, K 70,226
  • Annual Sales, $ 2,072 M
  • Annual Income, $ 418,300 K
  • EBIT $ 309 M
  • EBITDA $ 390 M
  • 60-Month Beta 1.30
  • Price/Sales 8.37
  • Price/Cash Flow 55.63
  • Price/Book 14.29

Options Overview Details

View History
  • Implied Volatility 54.11% ( -2.13%)
  • Historical Volatility 45.70%
  • IV Percentile 86%
  • IV Rank 63.08%
  • IV High 69.71% on 08/05/24
  • IV Low 27.45% on 12/16/24
  • Put/Call Vol Ratio 0.55
  • Today's Volume 17
  • Volume Avg (30-Day) 220
  • Put/Call OI Ratio 1.57
  • Today's Open Interest 9,799
  • Open Int (30-Day) 10,390

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.81
  • Number of Estimates 10
  • High Estimate 1.16
  • Low Estimate 0.65
  • Prior Year 0.73
  • Growth Rate Est. (year over year) +10.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
234.22 +5.06%
on 04/17/25
Period Open: 268.32
276.13 -10.89%
on 03/25/25
-22.26 (-8.29%)
since 03/21/25
3-Month
230.05 +6.96%
on 03/10/25
Period Open: 278.89
289.46 -14.99%
on 02/07/25
-32.83 (-11.77%)
since 01/22/25
52-Week
160.19 +53.61%
on 05/14/24
Period Open: 164.42
289.46 -14.99%
on 02/07/25
+81.65 (+49.66%)
since 04/22/24

Most Recent Stories

More News
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

UFPT : 206.71 (-1.86%)
BDX : 198.12 (+0.77%)
TFX : 130.32 (+0.91%)
PODD : 242.82 (+1.78%)
HAE : 57.98 (+1.72%)
5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

U.S. stock markets have been witnessing extreme volatility and one of the worst-performing phases in the last four trading sessions. The Dow fell more than 4,500 points during this period. The tech-heavy...

SRAD : 24.82 (+7.87%)
PODD : 242.82 (+1.78%)
SFM : 162.00 (+2.19%)
UNH : 423.80 (-0.36%)
GME : 27.74 (+3.62%)
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

RMD : 213.01 (+1.01%)
MASI : 150.95 (+1.15%)
PODD : 242.82 (+1.78%)
IRTC : 99.11 (+0.49%)
DXCM : 66.08 (-0.05%)
Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

New Diabetes Canada Guidelines1 recommend people with type 1 diabetes use an Automated Insulin Delivery System (AID) System for diabetes management...

PODD : 242.82 (+1.78%)
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

RMD : 213.01 (+1.01%)
MASI : 150.95 (+1.15%)
IRTC : 99.11 (+0.49%)
PODD : 242.82 (+1.78%)
DXCM : 66.08 (-0.05%)
Insulet Stock: Is PODD Outperforming the Healthcare Sector?

As Insulet has outperformed relative to the healthcare sector over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

XLV : 133.99 (+1.07%)
ABT : 130.79 (+0.69%)
PODD : 242.82 (+1.78%)
DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose...

ABT : 130.79 (+0.69%)
NVO : 59.38 (+1.80%)
PODD : 242.82 (+1.78%)
DXCM : 66.08 (-0.05%)
3 Reasons Investors Love Insulet (PODD)

3 Reasons Investors Love Insulet (PODD)

PODD : 242.82 (+1.78%)
DGX Stock Set to Benefit From New Google Cloud Partnership

Quest Diagnostics Inc. DGX recently announced a collaboration with Google Cloud, owned by the parent holding company, Alphabet GOOGL. The partnership aims to streamline Quest Diagnostics’ data management,...

GOOGL : 150.53 (+1.94%)
DGX : 171.22 (+5.78%)
BSX : 94.83 (+1.34%)
PODD : 242.82 (+1.78%)
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

RMD : 213.01 (+1.01%)
MASI : 150.95 (+1.15%)
PODD : 242.82 (+1.78%)
IRTC : 99.11 (+0.49%)
DXCM : 66.08 (-0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 249.95
2nd Resistance Point 247.25
1st Resistance Point 242.91
Last Price 242.82
1st Support Level 235.86
2nd Support Level 233.16
3rd Support Level 228.82

See More

52-Week High 289.46
Last Price 242.82
Fibonacci 61.8% 240.08
Fibonacci 50% 224.82
Fibonacci 38.2% 209.57
52-Week Low 160.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro